3-Aryl- and 3-heteroaryloxazolidin-2-ones, by virtue of the diverse
pharmacologic activities exhibited by them after subtle changes to
their appended substituents, are becoming increasingly important and
should be considered privileged chemical structures. The iodocyclocarbamation
reaction has been extensively used to make many 3-alkyl-5-(halomethyl)oxazolidin-2-ones, but the corresponding aromatic
congeners have been relatively underexplored. We suggest that racemic
3-aryl- and 3-heteroaryl-5-(iodomethyl)oxazolidin-2-ones, readily
prepared by the iodocyclocarbamation reaction of N-allylated N-aryl or N-heteroaryl carbamates, may
be useful intermediates for the rapid preparation of potential lead
compounds with biological activity. We exemplify this point by using
this approach to prepare racemic linezolid, an antibacterial agent.
Herein, we report the results of our systematic investigation into
the scope and limitations of this process and have identified some
distinguishing characteristics within the aryl/heteroaryl series.
We also describe the first preparation of 3-aryloxazolidin-2-ones
bearing new functionalized C-5 substituents derived from conjugated
1,3-dienyl and cumulated 1,2-dienyl carbamate precursors. Finally,
we describe the utility of the iodocyclocarbamation reaction for making
six-membered tetrahydro-3-aryl-1,3-oxazin-2-ones.